Παρασκευή 14 Δεκεμβρίου 2018
Steroid-induced perilymphatic hypopigmentation: Response to tacrolimus p. 114 Sneha Ghunawat, Rashmi Sarkar DOI:10.4103/Pigmentinternational.Pigmentinternational_11_18 Intralesional steroids are commonly used in dermatological practice. This route of administration has the advantage of minimal side effects. However, other adverse reactions namely local atrophy, ulceration, infections, etc. have been noted. One peculiar side effect following this route of administration “steroid-induced perilymphatic hypopigmentation and atrophy” has been described below. Although this condition repigments spontaneously, the use of tacrolimus to fasten the response has been highlighted in the case report.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Wordle is a toy for generating “word clouds” from text that you provide. The clouds give greater prominence to words that appear more freque...
-
Your source for quotations from famous people and literature. Search or browse over 27,000 quotations from thousands of authors. Includes th...
-
The population of American Indians and Alaska Natives (AIAN) in the USA, which comprise about 5 million individuals, have worse health outco...
-
SMARTCOCKPIT; Our #1 goal, since 2000, is to offer the most extensive online aviation resource to worldwide professional pilots. We desire t...
-
Abstract Purpose C-reactive protein and procalcitonin are reliable early predictors of infection after colorectal surgery. However, the ...
-
Famous Quotes: Hand Picked Funny, Inspirational and Love Quotes. Looking for the best famous quotes? from #AlexandrosSfakianakis via Alexa...
-
Economics articles & eBooks. Essays on topical issues, latest developments in UK and global economies, and answers to readers questions ...
-
Inspirational Quotations offers nature quotes celebrating the beauty of nature, flowers, rainbows, oceans, streams, and meadows. A free insp...
-
<span class="paragraphSection"><div class="boxTitle">Abstract</div>Despite many advances in the study ...

Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου